Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Telix Pharmaceuticals Limited - American Depositary Shares
(NQ:
TLX
)
6.420
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 17, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Telix Pharmaceuticals Limited - American Depositary Shares
< Previous
1
2
3
4
5
6
Next >
ARTMS Drug Master File for Gallium Production Technology Referenced with Telix’s Gozellix®
April 01, 2025
From
Telix ARTMS, Inc.
Via
GlobeNewswire
FDA Approves New Prostate Cancer Imaging Agent Gozellix®
March 21, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America
March 17, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Telix Adds Lead-212 Isotope Production Capability
March 12, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Investor Webinar: Telix Therapeutics Urology Showcase and Expert Forum
March 03, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review
February 25, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Recruitment Spotlight: Phase 3 Clinical Trial of Novel Prostate Cancer Radiopharmaceutical Now Active in Miami
February 25, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Bridge Investment Group, Telix Pharmaceuticals, Sun Communities, And Other Big Stocks Moving Higher On Monday
↗
February 24, 2025
Via
Benzinga
Stock Rebound Stalls; Nasdaq Down Triple Digits
↗
February 24, 2025
Stocks have pulled back from their premarket gains, with the Nasdaq Composite down 163 points and oscillating in and out of negative territory for 2025.
Via
Talk Markets
Topics
Stocks
Stocks / Equities
Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion
February 20, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Telix to Showcase Urology Pipeline at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2025)
February 13, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Illuccix® Approved in the United Kingdom
February 12, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
February 10, 2025
Via
Benzinga
Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
January 30, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Telix Completes Acquisition of RLS (USA) Inc.
January 27, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
SLB Posts Upbeat Results, Joins Bank OZK, Qorvo And Other Big Stocks Moving Higher On Friday
↗
January 17, 2025
Via
Benzinga
Illuccix® Receives European Approval
January 16, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Telix Presentation to the 43rd Annual J.P. Morgan Healthcare Conference
January 13, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Telix Exceeds FY24 Guidance with US$142M Q4 Revenue
January 13, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
January 12, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
NOBLE Registry Update: TLX599-CDx PSMA SPECT Imaging of Prostate Cancer Published in EJNMMI Reports
December 30, 2024
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging
December 29, 2024
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Telix Manufacturing Solutions, Brussels South Update: Cyclotron Installation Complete
December 19, 2024
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
December 12, 2024
Via
Benzinga
Telix to Add FAP-Targeting Candidates to Theranostic Pipeline
November 18, 2024
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
